Eve Holding, Inc. (EVEX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EVEX SEC filings page.
This page shows Eve Holding, Inc. (EVEX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Eve operates as a research-funded development business, with rising investment and losses increasingly financed through debt and equity.
From FY2024 to FY2025, research and development spending rose from$129.8M to$194.7M while operating cash outflow worsened from$136.0M to$160.4M . The pairing indicates that heavier investment has not yet translated into improving cash economics, so financing remains central to the operating model.
Balance-sheet leverage increased as long-term debt reached
FY2025 financing cash inflow of
Financial Health Signals
Eve Holding, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Eve Holding, Inc. passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
Eve Holding, Inc. reported a net loss of $224.3M while operations used $160.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Eve Holding, Inc. reported an operating loss of $225.4M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Eve Holding, Inc.'s EBITDA was -$36.7M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 31.7% from the same quarter a year earlier. Against the prior quarter it is up 44.3%.
Eve Holding, Inc. reported -$34.2M in net income in Q2 2026. This represents an increase of 47.1% from the same quarter a year earlier. Against the prior quarter it is up 50.3%.
Eve Holding, Inc. earned -$0.10 per diluted share (EPS) in Q2 2026. This represents an increase of 52.4% from the same quarter a year earlier. Against the prior quarter it is up 50.0%.
Not reported for Q2 2026.
Cash & Balance Sheet
Eve Holding, Inc. recorded an outflow of $48.3M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 15.0% from the same quarter a year earlier. Against the prior quarter it is up 29.6%.
Eve Holding, Inc. held $52.2M in cash against $303.1M in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Eve Holding, Inc.'s ROE was -149.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 331.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 27.2 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
Eve Holding, Inc. invested $28.9M in research and development in Q2 2026. This represents a decrease of 36.7% from the same quarter a year earlier. Against the prior quarter it is down 51.0%.
Eve Holding, Inc. invested $1.1M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 10.7% from the same quarter a year earlier. Against the prior quarter it is up 113.7%.
Not reported for Q2 2026.
EVEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $28.9M-36.7% | $59.1M+32.1% | N/A | $44.9M+38.4% | $45.7M+25.8% | $44.7M+62.9% | N/A | $32.4M+13.2% |
| SG&A Expenses | $8.3M+1.2% | $7.2M-8.2% | N/A | $7.0M-16.5% | $8.2M+51.9% | $7.9M+21.8% | N/A | $8.4M+67.1% |
| Operating Income | -$37.2M+30.9% | -$66.3M-26.1% | N/A | -$51.9M-27.1% | -$53.9M-29.1% | -$52.6M-55.0% | N/A | -$40.8M-21.2% |
| EBITDA | -$36.7M+31.7% | -$65.9M-25.5% | N/A | -$51.5M-26.5% | -$53.8M-29.1% | -$52.5M-55.0% | N/A | -$40.8M-21.2% |
| Interest Expense | $5.2M+118.9% | $4.6M+106.8% | N/A | $2.7M+219.9% | $2.4M+289.6% | $2.2M+442.2% | N/A | $835K+2593.5% |
| Income Tax | -$2.9M-759.8% | $95K+117.0% | N/A | $1.2M+186.9% | $435K+10.1% | -$558K-189.6% | N/A | $427K-61.1% |
| Net Income | -$34.2M+47.1% | -$68.8M-41.1% | N/A | -$46.9M-31.0% | -$64.7M-77.8% | -$48.8M-92.9% | N/A | -$35.8M-14.7% |
| EPS (Basic) | -$0.10+52.4% | -$0.20-25.0% | -$0.18-28.6% | -$0.14-16.7% | -$0.21-61.5% | -$0.16-77.8% | -$0.140.0% | -$0.12-9.1% |
| EPS (Diluted) | -$0.10+52.4% | -$0.20-25.0% | -$0.18-28.6% | -$0.14-16.7% | -$0.21-61.5% | -$0.16-77.8% | -$0.140.0% | -$0.12-9.1% |
| Diluted Shares (Avg) | 352M+15.8% | 352M+15.9% | N/A | 326M+9.5% | 304M+9.9% | 304M+9.9% | N/A | 298M+8.0% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit.
EVEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $457.7M+75.4% | $484.3M+59.2% | $434.9M+36.6% | $439.7M+51.9% | $261.0M+21.6% | $304.2M+33.2% | $318.2M+29.7% | $289.5M+10.7% |
| Current Assets | $421.2M+68.4% | $456.7M+53.4% | $410.9M+31.4% | $424.7M+48.8% | $250.1M+18.9% | $297.6M+32.7% | $312.8M+29.1% | $285.5M+10.0% |
| Cash & Equivalents | $52.2M+25.7% | $120.9M+103.2% | $103.2M+83.1% | $65.8M+168.0% | $41.5M+49.6% | $59.5M+152.3% | $56.4M+20.2% | $24.6M+143.4% |
| Short-Term Investments | $342.5M+70.2% | $311.6M+36.6% | $280.8M+13.7% | $344.2M+34.9% | $201.2M+115.8% | $228.1M+98.8% | $247.0M+122.1% | $255.3M+55.2% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $434.9M+75.7% | $428.2M+87.8% | $311.1M+60.1% | $255.6M+103.1% | $247.6M+126.2% | $228.0M+160.8% | $194.3M+142.0% | $125.9M+111.5% |
| Current Liabilities | $121.2M+34.4% | $120.3M+45.5% | $124.8M+110.3% | $81.5M+48.8% | $90.2M+66.0% | $82.7M+82.9% | $59.3M+14.1% | $54.8M+18.7% |
| Non-Current Liabilities | $313.7M+99.3% | $307.9M+111.8% | $186.3M+38.1% | $174.1M+145.0% | $157.4M+185.5% | $145.4M+244.2% | $135.0M+377.0% | $71.1M+432.6% |
| Long-Term Debt | $303.1M+96.8% | $295.8M+108.1% | $176.4M+33.6% | $167.3M+144.9% | $154.0M+192.8% | $142.2M+255.1% | $132.0M+412.4% | $68.3M+503.5% |
| Total Equity | $22.8M+69.9% | $56.1M-26.4% | $123.8M-0.1% | $184.1M+12.5% | $13.4M-87.2% | $76.1M-46.0% | $123.9M-24.9% | $163.7M-19.0% |
| Retained Earnings | -$810.1M-35.9% | -$775.9M-46.0% | -$707.1M-46.4% | -$643.2M-45.5% | -$596.3M-46.7% | -$531.6M-43.7% | -$482.8M-40.1% | -$442.1M-44.8% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
EVEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$47.2M+15.1% | -$68.1M-173.8% | -$25.9M+32.9% | -$54.0M-75.7% | -$55.6M-80.9% | -$24.9M+30.5% | -$38.7M-57.8% | -$30.7M-37.2% |
| Depreciation & Amortization | $517K+383.2% | $394K+380.5% | $388K+410.5% | $353K+426.9% | $107K+84.5% | $82K+60.8% | $76K+85.4% | $67K+80.0% |
| Stock-Based Compensation | N/A | $1.1M+10.6% | N/A | N/A | N/A | $1.0M-11.0% | N/A | N/A |
| Capital Expenditures | $1.1M-10.7% | $526K+13.4% | $4.1M+237.5% | $6.7M+108.0% | $1.3M+90.9% | $464K+337.7% | $1.2M | $3.2M+107766.7% |
| Free Cash Flow | -$48.3M+15.0% | -$68.6M-170.9% | -$30.0M+24.7% | -$60.7M-78.8% | -$56.9M-81.1% | -$25.3M+29.4% | -$39.9M-62.7% | -$34.0M-51.6% |
| Investing Cash Flow | -$30.1M-212.7% | -$31.5M-270.1% | $57.7M+897.7% | -$149.7M-84.3% | $26.7M+25.3% | $18.5M+980.2% | $5.8M-87.7% | -$81.2M-576.8% |
| Financing Cash Flow | $9.1M-18.8% | $117.1M+1161.9% | $12.8M-80.4% | $229.9M+111.3% | $11.2M-21.4% | $9.3M-37.1% | $65.2M+359.1% | $108.8M+888.8% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
EVEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -149.9%+331.6pp | -122.8%-58.7pp | N/A | -25.5%-3.6pp | -481.5%-446.9pp | -64.1%-46.1pp | N/A | -21.9%-6.4pp |
| Return on Assets | -7.5%+17.3pp | -14.2%+1.8pp | N/A | -10.7%+1.7pp | -24.8%-7.8pp | -16.0%-5.0pp | N/A | -12.4%-0.4pp |
| Current Ratio | 3.48+0.7x | 3.80+0.2x | 3.29-2.0x | 5.210.0x | 2.77-1.1x | 3.60-1.4x | 5.27+0.6x | 5.21-0.4x |
| Debt-to-Equity | 13.28+1.8x | 5.28+3.4x | 1.43+0.4x | 0.91+0.5x | 11.46+11.0x | 1.87+1.6x | 1.07+0.9x | 0.42+0.4x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Eve Holding, Inc. EVEX | FY2025 | N/A | -$224.3M | N/A | $592.4M | — |
| EHang Holdings Limited EH | FY2025 | $59.8M | -$39.5M | -66.0% | $314.0M | 50/100 |
| Redwire Corporation RDW | FY2025 | $335.4M | -$226.6M | -67.5% | $2.7B | 43/100 |
| Red Cat Holdings, Inc. RCAT | FY2025 | $40.7M | -$72.1M | N/A | $977.4M | 51/100 |
| Astronics Corp ATRO | FY2025 | $862.1M | $29.4M | 3.4% | $2.9B | 47/100 |
| Intuitive Machines, Inc. LUNR | FY2025 | $210.1M | -$83.3M | -39.6% | $2.4B | 37/100 |
Where Eve Holding, Inc. Ranks
Frequently Asked Questions
Is Eve Holding, Inc. profitable?
No, Eve Holding, Inc. (EVEX) reported a net income of -$224.3M in fiscal year 2025.
What is Eve Holding, Inc.'s EBITDA?
Eve Holding, Inc. (EVEX) had EBITDA of -$224.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Eve Holding, Inc. have?
As of fiscal year 2025, Eve Holding, Inc. (EVEX) had $103.2M in cash and equivalents against $176.4M in long-term debt.
What is Eve Holding, Inc.'s return on equity (ROE)?
Eve Holding, Inc. (EVEX) has a return on equity of -181.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Eve Holding, Inc.'s free cash flow?
Eve Holding, Inc. (EVEX) recorded an outflow of $173.0M in free cash flow during fiscal year 2025. This represents a -22.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Eve Holding, Inc.'s operating cash flow?
Eve Holding, Inc. (EVEX) recorded an outflow of $160.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Eve Holding, Inc.'s total assets?
Eve Holding, Inc. (EVEX) had $434.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Eve Holding, Inc.'s capital expenditures?
Eve Holding, Inc. (EVEX) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Eve Holding, Inc. spend on research and development?
Eve Holding, Inc. (EVEX) invested $194.7M in research and development during fiscal year 2025.
What is Eve Holding, Inc.'s current ratio?
Eve Holding, Inc. (EVEX) had a current ratio of 3.29 as of fiscal year 2025, which is generally considered healthy.
What is Eve Holding, Inc.'s debt-to-equity ratio?
Eve Holding, Inc. (EVEX) had a debt-to-equity ratio of 1.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Eve Holding, Inc.'s return on assets (ROA)?
Eve Holding, Inc. (EVEX) had a return on assets of -51.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Eve Holding, Inc.'s P/E ratio?
Eve Holding, Inc. (EVEX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $592.4M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Eve Holding, Inc.'s price-to-sales ratio?
Eve Holding, Inc. (EVEX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $592.4M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Eve Holding, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Eve Holding, Inc. (EVEX) held $384.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $160.4M over that year. Dividing the one by the other, the reported balance equals about 29 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Eve Holding, Inc.'s Piotroski F-Score?
Eve Holding, Inc. (EVEX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Eve Holding, Inc.'s earnings high quality?
Eve Holding, Inc. (EVEX) reported a net loss of $224.3M while operations used $160.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Eve Holding, Inc. cover its interest payments?
Eve Holding, Inc. (EVEX) reported an operating loss of $225.4M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.